CN104193814B - 青虾卵黄蛋白原Vg基因、编码蛋白及应用 - Google Patents

青虾卵黄蛋白原Vg基因、编码蛋白及应用 Download PDF

Info

Publication number
CN104193814B
CN104193814B CN201410456699.2A CN201410456699A CN104193814B CN 104193814 B CN104193814 B CN 104193814B CN 201410456699 A CN201410456699 A CN 201410456699A CN 104193814 B CN104193814 B CN 104193814B
Authority
CN
China
Prior art keywords
leu
ser
glu
lys
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410456699.2A
Other languages
English (en)
Other versions
CN104193814A (zh
Inventor
白鸿坤
傅洪拓
吴滟
乔慧
李法君
张文宜
龚永生
颜跃弟
金舒博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freshwater Fisheries Research Center of Chinese Academy of Fishery Sciences
Original Assignee
Freshwater Fisheries Research Center of Chinese Academy of Fishery Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Freshwater Fisheries Research Center of Chinese Academy of Fishery Sciences filed Critical Freshwater Fisheries Research Center of Chinese Academy of Fishery Sciences
Priority to CN201410456699.2A priority Critical patent/CN104193814B/zh
Publication of CN104193814A publication Critical patent/CN104193814A/zh
Application granted granted Critical
Publication of CN104193814B publication Critical patent/CN104193814B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/033Rearing or breeding invertebrates; New breeds of invertebrates
    • A01K67/0333Genetically modified invertebrates, e.g. transgenic, polyploid
    • A01K67/0337Genetically modified Arthropods
    • A01K67/0338Genetically modified Crustaceans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/05Animals modified by non-integrating nucleic acids, e.g. antisense, RNAi, morpholino, episomal vector, for non-therapeutic purpose

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Insects & Arthropods (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明公开一种青虾卵黄蛋白原Vg基因、编码蛋白及应用。利用本发明提供的引物组从青虾肝胰腺中克隆到了一种Vg基因全长cDNA序列,该基因dsRNA注入雌性青虾围心腔后可以沉默卵巢和肝脏内的卵黄蛋白原基因的表达,使青虾卵巢发育显著延缓。本发明为解决青虾性早熟现象,培育优良品种提供新的思路和有效手段。

Description

青虾卵黄蛋白原Vg基因、编码蛋白及应用
技术领域
本发明公开一种青虾卵黄蛋白原Vg基因、编码蛋白及应用,涉及生物技术和发育调控领域,具体涉及青虾卵黄蛋白原基因的克隆,还涉及利用该基因dsRNA来调控青虾卵巢的发育速度。
背景技术
青虾,学名日本沼虾(Macrobrachium nipponense),俗称河虾,隶属十足目(Decapoda)、长臂虾科(Palaemonidae)、沼虾属(Macrobrachium),广泛分布于我国各地水域,生长快、适应性强、养殖经济效益高,是我国重要的淡水养殖虾类。据2012年《中国渔业年鉴》记载,全国养殖青虾年产量超过23万吨,年产值超过150亿元,是目前淡水养殖业中最有发展前途的品种之一。近年来,随着其自然资源的锐减和养殖规模的扩大,养殖的青虾出现了生产性能下降和种质资源退化的情况,其中虾个体小型化和“性早熟”的现象尤为突出。“性早熟”即雌、雄性个体性腺提前发育,在生产中小虾性腺过早成熟,产卵导致个体变小、池塘养殖密度过大、生长规格不齐、近亲交配等一系列问题,最终商品虾的规格降低,繁殖性能下降,严重影响了青虾的品质和产值,成为青虾养殖业发展的一大瓶颈。为实现青虾产业的可持续发展,寻找解决雌性青虾“性早熟”的解决方法变得刻不容缓。
卵黄蛋白原(Vitellogenin,Vg)是一种普遍存在于卵生非哺乳动物血液中的蛋白,是几乎所有卵生动物中卵黄蛋白(vitellin,Vn)的前体。卵黄蛋白是所有卵生的脊椎动物和无脊椎动物雌性卵黄的主要成分,在卵黄发生期迅速积累。它被认为是由卵巢外组织合成,分泌释放到血液中,通过血液运输到***,以卵黄蛋白的形式积累和储存,是胚胎和幼体早期发育主要的营养来源。卵黄蛋白和卵黄蛋白原含有许多脂肪成分,可为正在发育的胚胎提供氨基酸、脂肪、碳水化合物、维生素、磷和硫等营养和功能性物质。
RNAi(RNA interference, RNAi)是一种广泛存在于真核生物中的高效的序列特异性基因剔除技术。RNAi是由不同来源和长度的双链 RNA(double-stranded RNA, dsRNA)前体所诱发的,可以有效地抑制靶基因RNA 的翻译。近年开始在甲壳动物基因功能研究中使用。目前,甲壳类关于Vg基因的沉默表达尚未见报道。
发明内容
本发明要解决的技术问题是提供一种青虾卵黄蛋白原Vg基因、编码蛋白及应用,该基因用于调控雌性青虾卵巢发育速度,为解决青虾性早熟提供理论基础。
技术方案:
一种青虾卵黄蛋白原,其氨基酸序列如SEQ ID NO.2所示。
编码上述青虾卵黄蛋白原的青虾卵黄蛋白原Vg基因。
所述的青虾卵黄蛋白原Vg基因,其核苷酸序列如SEQ ID NO.1中的第35位~第7645位所示。
所述的青虾卵黄蛋白原Vg基因所合成的dsRNA。
所述的青虾卵黄蛋白原Vg基因在延缓雌性青虾卵巢发育中的应用。
所述的应用,包括如下步骤:对青虾DNA样本中的青虾卵黄蛋白原Vg基因进行PCR扩增,将扩增产物进行体外转录合成dsRNA,再将dsRNA以注射到青虾的围心腔内。
所述的应用,PCR扩增中使用的上下游引物的序列如SEQ ID NO.3~4所示。
所述的应用,注射步骤中的注射剂量是4μg/g。
有益效果
本发明提供的青虾卵黄蛋白原Vg基因可以制备得到dsRNA,通过注射的方式注入青虾围心腔内,可以有效地延缓青虾卵巢成熟的时间,证明该基因的表达对雌性卵巢发育有非常重要的影响。
附图说明
图1是外源性注射Vg-dsRNA对雌性青虾卵巢GSI性腺发育指数影响的示意图。
注: 1d,3d, 5d, 7d, 9d, 11d, 13d, 15d,17d分别为注射后1,3,5,7,9,13,15和17天(样本量N≥ 3)。
图2是外源性注射Vg-dsRNA对雌性青虾内源Vg基因的表达量影响的示意图。
注: 1d, 3d, 5d, 7d, 9d,11d, 13d, 15d,17d分别为注射后1,3,5,7,9,13,15和17天(样本量N≥ 3)。对照组注射相同剂量的DEPC水。
图3是在肝脏中外源性注射Vg-dsRNA对雌性青虾内源Vg基因的表达量的影响的示意图。
注: 1d,3d, 5d, 7d, 9d, 11d, 13d, 15d,17d分别为注射后1,3,5,7,9,13,15和17天(样本量N≥3)。对照组注射相同剂量的DEPC水。
具体实施方式
下面通过具体实施方式对本发明作进一步详细说明。但本领域技术人员将会理解,下列实施例仅用于说明本发明,而不应视为限定本发明的范围。实施例中未注明具体技术或条件者,按照本领域内的文献所描述的技术或条件(例如参考J. 萨姆布鲁克等著,黄培堂等译的《分子克隆实验指南》,第三版,科学出版社)或者按照产品说明书进行。所用试剂或仪器未注明生产厂商者,均为可以通过市购获得的常规产品。
本文使用的近似语在整个说明书和权利要求书中可用于修饰任何数量表述,其可在不导致其相关的基本功能发生变化的条件下准许进行改变。因此,由诸如“约”的术语修饰的值并不局限于所指定的精确值。在至少一些情况下,近似语可与用于测量该值的仪器的精度相对应。除非上下文或语句中另有指出,否则范围界限可以进行组合和/或互换,并且这种范围被确定为且包括本文中所包括的所有子范围。除了在操作实施例中或其他地方中指明之外,说明书和权利要求书中所使用的所有表示成分的量、反应条件等等的数字或表达在所有情况下都应被理解为受到词语“约”的修饰。
本研究的目的就是通过用Vg-dsRNA 注入青虾体内,研究该基因在dsRNA 刺激下的表达变化以及对卵巢发育的影响,阐释 dsRNA 对青虾卵巢发育的调节机制,为利用Vg-dsRNA干扰技术抗性早熟的实用化提供新思路和参考依据。
实施例1:青虾Vg基因全长cDNA的获得
总RNA提取:选取3~4支成熟雌虾的肝脏,迅速放入盛有液氮的预冷研钵中,迅速的研磨。总RNA的提取使用Takara公司的RNAiso Plus提取试剂结合传统的酚仿抽提法进行,提取方法参照使用说明书。经过琼脂糖凝胶电泳检测RNA的质量,分光光度计分析该样品OD260/280 比值在1.8~2.0 之间,并测定RNA的浓度。
cDNA第一链合成:参照Takara M-MLV反转录试剂盒进行第一链cDNA的合成。
青虾Vg基因全长cDNA序列的克隆:
根据已获得的Vg基因全长cDNA序列(罗氏沼虾Macrobrachium rosenbergii,BAB69831;日本仿长额虾Pandalopsis japonica, ACU51164; 高背长额虾Pandalus hypsinotus BAD11098;)的编码区进行比对,依据比对结果,在保守区域设计引物,利用引物组一(SEQ ID NO:5~SEQ ID NO:14) 和上述反转录的cDNA为模板进行中间片段的克隆。
更具体地,上述的引物组的组成如下:
正向引物VGAF1的核苷酸序列如SEQ ID NO.5所示;
正向引物VGBF2的核苷酸序列如SEQ ID NO.6所示;
正向引物VGCF3的核苷酸序列如SEQ ID NO.7所示;
正向引物VGDF4的核苷酸序列如SEQ ID NO.8所示;
正向引物VGEF5的核苷酸序列如SEQ ID NO.9所示;
反向引物VGAR1的核苷酸序列如SEQ ID NO.10所示;
反向引物VGBR2的核苷酸序列如SEQ ID NO.11所示;
反向引物VGCR3的核苷酸序列如SEQ ID NO.12所示;
反向引物VGDR4的核苷酸序列如SEQ ID NO.13所示;
反向引物VGER5的核苷酸序列如SEQ ID NO.14所示。
进行PCR扩增反应体系如下:
PCR反应程序为:94℃预变性3min,然后进入下列循环:94℃ 30s,55℃ 30s,72℃30s,30个循环,最后72℃延伸10min,4℃保存。1.5%琼脂糖凝胶电泳检测。
利用上海生工生物工程有限公司(Sangon)的柱式DNA 胶回收试剂盒进行目的片段的回收,将产物连接到pMD18-T载体(Takara),并转化入大肠杆菌DH5α,进行蓝白斑筛选,挑取单克隆白斑扩增培养后,将***目的片段的阳性克隆送至上海铂尚生物公司进行测序分析。将得到的几段产物进行拼接,得到青虾Vg基因的中间片段。
根据Vg基因cDNA中间片段序列,又设计特异性正向引物3VGF1(SEQ ID NO.15)、3VGF2(SEQ ID NO.16);和反向引物5VGR1(SEQ ID NO.17)、5VGR2(SEQ ID NO.18)分别进行cDNA 3’和5’快速扩增,操作步骤按TaKaRa 3’-RACE和TaKaRa5’-RACE试剂盒说明书进行。按上述克隆的步骤进行随后的切胶、回收、转化、克隆及测序最终得到Vg 基因的3’和5’端的序列。将中间片段和3’和5’端的测序结果进行比对,拼接得到青虾Vg基因全长cDNA序列。经过序列比对显示,青虾Vg基因和其它甲壳类的同源性在70%以上。其核苷酸序列如SEQ IDNO.1中的第35位~第7645位所示(第1~34和第7646~7800位是3’和5’端的非编码区),其编码蛋白的氨基酸序列如SEQ ID NO.2所示。
实施例2:青虾Vg基因dsRNA的合成
以SEQ ID NO.1核苷酸序列为依据,在开放阅读框以内采用NCBI在线dsRNA引物设计软件(http://www.flyrnai.org/cgi-bin/RNAi_find_primers.pl)设计制备双链RNA 的引物(SEQ ID NO.3- SEQ ID NO.4),根据Transcript AidTM T7 High YieldTranscription kit (Fermentas, Inc., USA)试剂盒说明进行体外转录合成dsRNA。将制备好的dsRNA溶解在DEPC 水中,测定其浓度并在1.5%琼脂糖凝胶上检测其纯度。将上述dsRNA溶液以4μg/g的剂量注射到青虾的围心腔内。对照组注射相同体积的DEPC 水,实验所用的雌虾都处于卵巢发育初期(刚排完卵)。在注射后的第1、3、5、7、9、11、13、15和17天收集样品(N≥3),并将组织保存在RNA 保存液中(Takara)。最后提取各样品的总RNA并反转成cDNA,采用Real Time PCR检测Vg基因相对于对照组的表达量变化,以此来计算Vg基因干扰的效率。性腺指数是评价动物性腺发育状况的重要指标。根据公式GSI=性腺湿重/体重湿重×100%,计算两组雌性青虾的GSI性腺发育指数(Gonad Somatic Index,GSI)。
实验结果
图1所示,为对照组的GSI性腺发育指数和注射组的性腺发育指数对比的示意图,可以看出Vg-dsRNA 注射显著延缓了青虾卵巢的发育在第11天对照组卵巢发育已处于成熟期实验组仍处于卵黄积累时期。
如图2所示,在卵巢中,相对于对照组,注射后第1天,青虾Vg基因的表达量显著下降了76%,在第5天已经下降了92%,随着对照组卵巢的发育,Vg 基因在卵巢中呈现了先升高后降低的表达规律。然而在对照组这一规律明显被延后,在第15天时处理组处于卵黄发生的高峰期,而对照组卵巢已完成一轮发育周期,已经排空。
如图3所示,在肝脏中,相对于对照组,注射后第1天,青虾Vg基因的表达量显著下降了74%,在第5天已经下降了97%,随着对照组卵巢的发育,Vg 基因在肝脏中同样呈现了先升高后降低的表达规律。根据表达规律来看对照组的发育明显被延缓。结果证明外源注射Vg-dsRNA ,可以有效地延缓性腺发育,这一研究结果为解决青虾性早熟这一难题提供了理论基础,也为后续将该方法应用到生产实践提供指导意义。
SEQUENCE LISTING
<110> 中国水产科学研究院淡水渔业研究中心
<120> 青虾卵黄蛋白原Vg基因、编码蛋白及应用
<130> 无
<160> 18
<170> PatentIn version 3.5
<210> 1
<211> 7800
<212> DNA
<213> vg
<400> 1
aaagtagttg tggtgacaac ctcctcctgc caccatgacc tccttggctc ttctcctcct 60
tgccatagct tccttttcac cagctccttg gccatcagga actaacttat gctcaaagga 120
atgcccagtt gccggatcgc ccaaactctt ctacgcccct gaaaagactt atgtttactc 180
atacactggc aagtcccgga tccacctgaa ggatgttgaa ggggccaacg tagacatgga 240
atggaactcc caggtcgagc tttcgtggct ctccccctgt gatatggcca tcaccatgaa 300
gaatccttcc attggaggtg gttcaggttc tgctgaagcc aggttcctcg agagatatcc 360
cttagtggtg tctatcattg acggacgggt gaaagcagcc tgtggccatc ctgatgatga 420
cacttggtct atcaacttga aaaagggcat tgcatcagct ttccagaaca ccttaccctc 480
caactccacc atcaactcag gccttaactt cacagagact gatataattg gtaactgttc 540
aactgtgtat gaagtgcaac atgagggaga aaaggttgtt gtgaccaagt tgaaaaacca 600
tcgcttctgc caagatcatt acgctaaccg agctgagaca ccaaaagctt ggatgaaggc 660
tcctttgcct atggaagaat cctactctga atgcaaacag gaaattacaa atggtattta 720
caccagcatt acttgtaagg acaagaatgt cataaaacca gcctatggtt cttacaagta 780
cgttgaagcc caccaagaat cagttttacg attccagtca gaaacagacc agattcctcc 840
ttcagtttct cagctgccta gccgcttcat caggaagact cttcgttatg accagcacac 900
actaaagaag gatccatcaa tggcggccaa acttgacgaa atgctcaaac aagtatgcga 960
aaaggtgaag cacggagtcc acgaacatgc agcatctcaa tttgcccaag ccttacattt 1020
cttgcgccgt gtacctgaag aggcaatccc acaaaccctc gagaagatcc gtggtggcca 1080
aatctgtgaa caacgtcaaa agatggagag catgttctta gacggattag cttttgttta 1140
cgaatctgga gcagtcaagg ttatggtgca agagttgatt tctggaaaag ctactggagg 1200
tcgagctgct ctttatgctg cttcaatgta cttcatgccc cgaccatgca ttcactccat 1260
tgaagccttg aaacctctgt ttgaaaattt ccagcgtttc ccaaggacca ctttagctgg 1320
tgccaccatg gtccatactt actgcagaca aaatcctaaa tgccaagaaa aagctcctgt 1380
cagacagtta gctgagactt taagcagcaa agtaggacaa atgtgcactg cctcaccaaa 1440
tgaagaaact agagagcatg ctcttgctct actcaagtcc cttggcaata tgggggtgat 1500
gaattctgaa atagccagac caatcttgca gtgcatagaa aacccagaag ctgataaagg 1560
catccgtagg gcagccaccc agaccttcag gaacgttcac tgtcatcaag aaatccaccc 1620
aataatgaaa cagctcatta acgttgctct tgatcataga aagagaaccg aagttcgaat 1680
tggatcatat cttgcagcaa ttaaatgtgc taaacatgaa gaactgcaca agattactga 1740
aaaaatagct aaggaagaaa atacacaagt gagaagtttc atcttaagcc atctgcacaa 1800
tatcaaggaa tcaactgtcc cttacaaggc aaatctcaaa tctaggcttg aaagtatagt 1860
ccttccctct aacttcacca aagactggcg aaagcactcc cgcaatatcg acctgtctta 1920
ctatgcacca acctttggcg taggtgctgg tgtggagtct aatgtcattt atgctccagg 1980
atcttatgtt cctcgctcgg ttaacctaaa tctcacagca gcccttggtg caacaccctt 2040
caatattgga gagattggag cacgttttga aggactcgag acaattatag aagaactttt 2100
cgggccacac agttacttca agagaactcc agcaagacag atctgggaag atctcaaaga 2160
gacacttagc aagataagcg aacgtttaga aggctcattc aggcagagaa ggtctattga 2220
cttgtcccaa atctctcatc tctttgacaa actatatggc aacagacaca tgcagaaagc 2280
tgatatttat gctcggatta ataatcaaga aatggccttt ggatcttggg aaggaaatat 2340
gaaaaatatc aagatcgacg aacttatcaa taacttattt gataagtttg acaacgtgat 2400
taacagagca gcaaccacca acatcgatac agtaagaaca gctcagtttt acatgaacaa 2460
tcatttgcct acaattcaag gattacccat caaaattaaa ctggagggaa cagctgtggc 2520
cggaattaag atggaaactc acgtcagagg actcacctct ggaactcctg gtgttgtcaa 2580
gttcttgcca agtttatcaa ctcaaataga tgcatttata ggttatgact gtcacattgt 2640
tcgtgctgga attaagatga agaatcacat tgccacaaac tatggagcaa gcattaatgc 2700
taaatacaca tctggtcaag gctttgaagt agaattagaa atgccagaga aaatggagtt 2760
gctgaaagca cagagtgaaa cttaccttat gaagagagta aagggtcaac aggagaccaa 2820
agttcatcct tcctctgtac agagcacacg attccagact cagtcttgtt taacgaaaat 2880
ggaaccagtt cttggactca aactctgcta cgacgtcaac atgccaaaca ttttccgtag 2940
tcaaggtctt ccacttggtc ctcctgctat tttcaaggtc gtcttagaga aggcggaatc 3000
tggaatgaga ggattccttg taaagggcag agaagaacat gttggaggaa agaaggtgat 3060
taaagtcgag ctagaaactc caggaacctc ctcacctaag aaagctactg ccatcattac 3120
atcagctaat gaaggagagg aaaagaaaat atctgcaaca tttgaatgtg aacgtttggg 3180
aggaatcagc atccatatga tgagaaagtg gactcagtca gaaaaacaag tcgagatgat 3240
tgcctatttc agtgaaagca gacagtacaa tcctagtacg aagggcatgg aagctaaatt 3300
cttatggaat ggcgaaggag aagaggttaa attggatatg gcattgaata cattagctgc 3360
catcagagaa tgggtacaac tcaactttga agttagcgga gatctgaggt atcatgaatg 3420
gtgcagaata cctcttccac aaagactgcg caaattcgaa actaaagtag cacttagaaa 3480
ttggcacatc atttctttca tgagaaagga aggtgaatcc caatacaagt caactctcaa 3540
gattggtcaa cgaggaaatg aaaagattga tataattggc aaccatgtca tggaaggaag 3600
ttcatacaga gatatgacct tcaaatctaa catagaagct aaaattggaa atgccagata 3660
caagaaaaac tttgttttat acaaccaaga aagtaaaatg ggagttgaat ggcaagtggc 3720
ttcccaagaa ggtggaaagg ttattgaatt agaaatgatg ctaattcggt cgggagagac 3780
atctcaagtc aaatttttgc ttgatattcc cgagcgcatg aagaaagtcc tgctcgaagc 3840
ctctgcagca ggccaaggaa gctctcagta ccaagtcaga gcaatggcca agtatggaga 3900
aagtcctatt ttccatgtag aaggaccagt caccgcaatg ctctcatcta aaaacactca 3960
cctcaagacc gaattgagga ctgttttact tcgcagccaa ccctacacag tcacaacctc 4020
tcttgtaatg atgcatggca aacaagccgt tgtctttgaa ctaaaagaca gagaagaaca 4080
tctcattact gtgcaatgga atatggcgac tcgagatgga caggaaaccc atctggattt 4140
taaaatgctc attccatcca tgatagaaaa gacaatgaat gccattgtca gtgagaaagt 4200
ctttcacttg agtgtcaacc agctgatagg accaaagagc tcttccccac tgagaaggaa 4260
aggtttcttg gatgttgatt tcgaaggcaa gagagcaaac gtcgaatttg cttgggacgc 4320
tgatcgtaac ccaaataaga aaattaaggc tgaagtcaaa atggttaatc cactttcaac 4380
tctacgagac tgtgttgtcc agggtaactg ggcctactta gagagacaac atcaattcaa 4440
ggctgaactg aaactcagtg acatccgctc ttggtttgtt ggaaggaaca gcttgatgct 4500
agaggtaaca aaccccaatc aacaaatgta caaaatgaat tctatcttaa tggtggagaa 4560
aaagggatca ggaccaaaag taggggcaga cataaccttc aggacacctg aaaacagaga 4620
gtataagtgg aattccgaaa gttctcttga gtgccgcgaa ggactacaga acgtgaggct 4680
gatgaccaaa gcagatcttg tttggccaga aggtcgacaa tctatagtaa acttagaagc 4740
aatgcatcgc tggacaccta gccaaaggga agctgaatta aagattgaag tgacctgccc 4800
atcactccca caaccaatca agaccaaact tcagctgaat aatcaacagg gtgaatacag 4860
taccaagtgg gtcattgaaa tgggctttcc agtaaatggt gcaatgtaca aactaaaatt 4920
gtctcctgag catggagtac aagggttcga agtagaactt aacctagaag aagtacttaa 4980
gctcctgaag gcgatagatc acctcatatc ttctagctct ttgtccatgt ctgatagccc 5040
tcggcgtctg ctctttatcg tgctcactac aaacatcatg accaccattc ttattccctg 5100
ttgcctgatg tcaccctctc gtacaatgga aggaggatgt ggatgcaata cttgcacagg 5160
cccaagttgt gctgactgcc attgcagctt cgttcctcat aagggtttaa gtgattccaa 5220
atatgagatt gccttccgcc gatctcattc cgattggagt ggagaatcca gatatgaagg 5280
tcgtgtcagc catccaggac tagagaggga ccgtcgaatt gatattcagc ttagaagaga 5340
ggaacagaag gtcacaggaa gtgttgagct cgatattttc ctcagaccag aagataagat 5400
cactggaaag ttagaatcac tcatttatgc tcgaaacact gtcatcgttg aagcaaaact 5460
tgaaggaaag gtactgaagg atcaccccaa ggtcattgta cgtggagcct atggtccaag 5520
caatgttgga tttgatatta aattgcacaa gactcactct tctcctacat ccttcaggat 5580
gtcgggaaga tatgagaaga ggactgccag aaatgccgct gcttccttca tcatagagaa 5640
tgaacatcaa aaaaccattg acatttctat agcacttcat cctcatcaga gtccttggtg 5700
ttatggagta cgagctgaag ctaaggcaaa gtcgtccatc attggaactt acgacatcta 5760
ttctgagctt tgcaagccag gatttgtatc attgaccaca aagaaacatg gaagtgacaa 5820
gatgtacata actaaactcg gtatagaagg aatgaagaac atcgaagcca gtattttgga 5880
agctaaccca caaaccatgg agaaaagacc acttggcatg gctcgtatgg tgctaacttc 5940
tcccacaatg atgaagctgg aaactaagta tgaaggtgat aagctacatg aaatcaagag 6000
tactgtacgc gatatgtggt ggaggcttgt ttcatctgca ggtaacggga tggattcttt 6060
gtgcagtgaa gttttacaag agggctctgg atcaccttct ggccacatgt cttcggtatg 6120
gcgggaaatt aagaatgaag cctcaagaat ctattctgat ttggaaaacg atttagtcat 6180
tcctaaatat gagaagctca gggaatggct tcatggtggc attctctcta acattgccga 6240
gggatgttca aaggtttggt ctcattatgc tcacttccaa agcagtttat catcatctgt 6300
atccaacatg ataagaacta ttcgagagga attccctgga ttaactagag tagtcactga 6360
agttgtaatg ggaactgctc gtggcctgca aactggtgaa atgccggagg tgttccgtcg 6420
atggtggaac gatttccttg agagttcttt ctgcagggct atagcatctg actttgaatc 6480
actctggagt gaacaccaag aggagtacca gggattgcag cagatctgga ggaaaatcaa 6540
gaacactctt gcaaaggacg ttaacagaca gagacgtaat cttatgcact acaagaaacc 6600
caggcatctt gttaactgga tcgtccacga catgaacttt gaacgaatgg ttttcaaggg 6660
tgtagataag gttatcaaga atgttgtgca gaaagctctc ttcgtacctt ttcagatcga 6720
tggtaaccac ttccagcttc agttacctat tcgtcgacca gtgcactcac ttcctcaagc 6780
tttgtcttat gtatcaatga atccaactcc agttgttgac cgtgcattat ggtggtttga 6840
agctcttatg cccactccag tcgataacat tgtatgggct tattataaat tccttcctcg 6900
ccatgcacgt tatcttctgc caccctacaa tcacacagcc atggttgttg atggatcaga 6960
gatcctcacc tttgatggag tagttctgcg agtacctcat tctccctgca aagtcttgct 7020
tgcacagtac aagactcact ccttgattat gcaaaatcag cagcctggcc atttgccaca 7080
cttcattttg aaggctgctg gagctacagt ggaggtcaag cctgacttcg ttgttaccgt 7140
caatggaaat ccagtaagtg ggcccaggga agtgcaaggt gaagtcgtaa tcatgaaaga 7200
aaatgagaag atcaaggtca ggactccatt cataacactc cgtgtctaca aagacagccg 7260
caccgcttca gtcgaggtgt ctggctggac atttggtaga atagctggtc ttttgggcat 7320
ctatgatggg gaaaaggcaa ctgataggtt gacacctcag ggtacaaggg catctaatct 7380
tcaagagctg gtcaagtcct ggcaagagaa tcctcagtgc gagactcctc acgtagcccc 7440
catgagtcct atgcaggttc cagtggtcca tatgctccac tgccaaaccc tcttcggagt 7500
tcggtctcgc tgcaacccag tcgtccatcc agggccattc aggaagatgt gcttcgccag 7560
caagaacgcc tgtcacgttg ctaaggccta tcgggccatg tgcgagacga agggcattaa 7620
ggagaccttc cctctgggat gctaatgacc aaacctatcc atggaagtca ttgtgtaaat 7680
gagtgactcc aagcctagtg acctcattgt tctagttttt aagaaatgca acgaaaatgt 7740
acaaaaaata ataaatttct agatcgataa taaatatgag atgcataaca agaaaaaaaa 7800
<210> 2
<211> 2536
<212> PRT
<213> vg-prt
<400> 2
Met Thr Ser Leu Ala Leu Leu Leu Leu Ala Ile Ala Ser Phe Ser Pro
1 5 10 15
Ala Pro Trp Pro Ser Gly Thr Asn Leu Cys Ser Lys Glu Cys Pro Val
20 25 30
Ala Gly Ser Pro Lys Leu Phe Tyr Ala Pro Glu Lys Thr Tyr Val Tyr
35 40 45
Ser Tyr Thr Gly Lys Ser Arg Ile His Leu Lys Asp Val Glu Gly Ala
50 55 60
Asn Val Asp Met Glu Trp Asn Ser Gln Val Glu Leu Ser Trp Leu Ser
65 70 75 80
Pro Cys Asp Met Ala Ile Thr Met Lys Asn Pro Ser Ile Gly Gly Gly
85 90 95
Ser Gly Ser Ala Glu Ala Arg Phe Leu Glu Arg Tyr Pro Leu Val Val
100 105 110
Ser Ile Ile Asp Gly Arg Val Lys Ala Ala Cys Gly His Pro Asp Asp
115 120 125
Asp Thr Trp Ser Ile Asn Leu Lys Lys Gly Ile Ala Ser Ala Phe Gln
130 135 140
Asn Thr Leu Pro Ser Asn Ser Thr Ile Asn Ser Gly Leu Asn Phe Thr
145 150 155 160
Glu Thr Asp Ile Ile Gly Asn Cys Ser Thr Val Tyr Glu Val Gln His
165 170 175
Glu Gly Glu Lys Val Val Val Thr Lys Leu Lys Asn His Arg Phe Cys
180 185 190
Gln Asp His Tyr Ala Asn Arg Ala Glu Thr Pro Lys Ala Trp Met Lys
195 200 205
Ala Pro Leu Pro Met Glu Glu Ser Tyr Ser Glu Cys Lys Gln Glu Ile
210 215 220
Thr Asn Gly Ile Tyr Thr Ser Ile Thr Cys Lys Asp Lys Asn Val Ile
225 230 235 240
Lys Pro Ala Tyr Gly Ser Tyr Lys Tyr Val Glu Ala His Gln Glu Ser
245 250 255
Val Leu Arg Phe Gln Ser Glu Thr Asp Gln Ile Pro Pro Ser Val Ser
260 265 270
Gln Leu Pro Ser Arg Phe Ile Arg Lys Thr Leu Arg Tyr Asp Gln His
275 280 285
Thr Leu Lys Lys Asp Pro Ser Met Ala Ala Lys Leu Asp Glu Met Leu
290 295 300
Lys Gln Val Cys Glu Lys Val Lys His Gly Val His Glu His Ala Ala
305 310 315 320
Ser Gln Phe Ala Gln Ala Leu His Phe Leu Arg Arg Val Pro Glu Glu
325 330 335
Ala Ile Pro Gln Thr Leu Glu Lys Ile Arg Gly Gly Gln Ile Cys Glu
340 345 350
Gln Arg Gln Lys Met Glu Ser Met Phe Leu Asp Gly Leu Ala Phe Val
355 360 365
Tyr Glu Ser Gly Ala Val Lys Val Met Val Gln Glu Leu Ile Ser Gly
370 375 380
Lys Ala Thr Gly Gly Arg Ala Ala Leu Tyr Ala Ala Ser Met Tyr Phe
385 390 395 400
Met Pro Arg Pro Cys Ile His Ser Ile Glu Ala Leu Lys Pro Leu Phe
405 410 415
Glu Asn Phe Gln Arg Phe Pro Arg Thr Thr Leu Ala Gly Ala Thr Met
420 425 430
Val His Thr Tyr Cys Arg Gln Asn Pro Lys Cys Gln Glu Lys Ala Pro
435 440 445
Val Arg Gln Leu Ala Glu Thr Leu Ser Ser Lys Val Gly Gln Met Cys
450 455 460
Thr Ala Ser Pro Asn Glu Glu Thr Arg Glu His Ala Leu Ala Leu Leu
465 470 475 480
Lys Ser Leu Gly Asn Met Gly Val Met Asn Ser Glu Ile Ala Arg Pro
485 490 495
Ile Leu Gln Cys Ile Glu Asn Pro Glu Ala Asp Lys Gly Ile Arg Arg
500 505 510
Ala Ala Thr Gln Thr Phe Arg Asn Val His Cys His Gln Glu Ile His
515 520 525
Pro Ile Met Lys Gln Leu Ile Asn Val Ala Leu Asp His Arg Lys Arg
530 535 540
Thr Glu Val Arg Ile Gly Ser Tyr Leu Ala Ala Ile Lys Cys Ala Lys
545 550 555 560
His Glu Glu Leu His Lys Ile Thr Glu Lys Ile Ala Lys Glu Glu Asn
565 570 575
Thr Gln Val Arg Ser Phe Ile Leu Ser His Leu His Asn Ile Lys Glu
580 585 590
Ser Thr Val Pro Tyr Lys Ala Asn Leu Lys Ser Arg Leu Glu Ser Ile
595 600 605
Val Leu Pro Ser Asn Phe Thr Lys Asp Trp Arg Lys His Ser Arg Asn
610 615 620
Ile Asp Leu Ser Tyr Tyr Ala Pro Thr Phe Gly Val Gly Ala Gly Val
625 630 635 640
Glu Ser Asn Val Ile Tyr Ala Pro Gly Ser Tyr Val Pro Arg Ser Val
645 650 655
Asn Leu Asn Leu Thr Ala Ala Leu Gly Ala Thr Pro Phe Asn Ile Gly
660 665 670
Glu Ile Gly Ala Arg Phe Glu Gly Leu Glu Thr Ile Ile Glu Glu Leu
675 680 685
Phe Gly Pro His Ser Tyr Phe Lys Arg Thr Pro Ala Arg Gln Ile Trp
690 695 700
Glu Asp Leu Lys Glu Thr Leu Ser Lys Ile Ser Glu Arg Leu Glu Gly
705 710 715 720
Ser Phe Arg Gln Arg Arg Ser Ile Asp Leu Ser Gln Ile Ser His Leu
725 730 735
Phe Asp Lys Leu Tyr Gly Asn Arg His Met Gln Lys Ala Asp Ile Tyr
740 745 750
Ala Arg Ile Asn Asn Gln Glu Met Ala Phe Gly Ser Trp Glu Gly Asn
755 760 765
Met Lys Asn Ile Lys Ile Asp Glu Leu Ile Asn Asn Leu Phe Asp Lys
770 775 780
Phe Asp Asn Val Ile Asn Arg Ala Ala Thr Thr Asn Ile Asp Thr Val
785 790 795 800
Arg Thr Ala Gln Phe Tyr Met Asn Asn His Leu Pro Thr Ile Gln Gly
805 810 815
Leu Pro Ile Lys Ile Lys Leu Glu Gly Thr Ala Val Ala Gly Ile Lys
820 825 830
Met Glu Thr His Val Arg Gly Leu Thr Ser Gly Thr Pro Gly Val Val
835 840 845
Lys Phe Leu Pro Ser Leu Ser Thr Gln Ile Asp Ala Phe Ile Gly Tyr
850 855 860
Asp Cys His Ile Val Arg Ala Gly Ile Lys Met Lys Asn His Ile Ala
865 870 875 880
Thr Asn Tyr Gly Ala Ser Ile Asn Ala Lys Tyr Thr Ser Gly Gln Gly
885 890 895
Phe Glu Val Glu Leu Glu Met Pro Glu Lys Met Glu Leu Leu Lys Ala
900 905 910
Gln Ser Glu Thr Tyr Leu Met Lys Arg Val Lys Gly Gln Gln Glu Thr
915 920 925
Lys Val His Pro Ser Ser Val Gln Ser Thr Arg Phe Gln Thr Gln Ser
930 935 940
Cys Leu Thr Lys Met Glu Pro Val Leu Gly Leu Lys Leu Cys Tyr Asp
945 950 955 960
Val Asn Met Pro Asn Ile Phe Arg Ser Gln Gly Leu Pro Leu Gly Pro
965 970 975
Pro Ala Ile Phe Lys Val Val Leu Glu Lys Ala Glu Ser Gly Met Arg
980 985 990
Gly Phe Leu Val Lys Gly Arg Glu Glu His Val Gly Gly Lys Lys Val
995 1000 1005
Ile Lys Val Glu Leu Glu Thr Pro Gly Thr Ser Ser Pro Lys Lys
1010 1015 1020
Ala Thr Ala Ile Ile Thr Ser Ala Asn Glu Gly Glu Glu Lys Lys
1025 1030 1035
Ile Ser Ala Thr Phe Glu Cys Glu Arg Leu Gly Gly Ile Ser Ile
1040 1045 1050
His Met Met Arg Lys Trp Thr Gln Ser Glu Lys Gln Val Glu Met
1055 1060 1065
Ile Ala Tyr Phe Ser Glu Ser Arg Gln Tyr Asn Pro Ser Thr Lys
1070 1075 1080
Gly Met Glu Ala Lys Phe Leu Trp Asn Gly Glu Gly Glu Glu Val
1085 1090 1095
Lys Leu Asp Met Ala Leu Asn Thr Leu Ala Ala Ile Arg Glu Trp
1100 1105 1110
Val Gln Leu Asn Phe Glu Val Ser Gly Asp Leu Arg Tyr His Glu
1115 1120 1125
Trp Cys Arg Ile Pro Leu Pro Gln Arg Leu Arg Lys Phe Glu Thr
1130 1135 1140
Lys Val Ala Leu Arg Asn Trp His Ile Ile Ser Phe Met Arg Lys
1145 1150 1155
Glu Gly Glu Ser Gln Tyr Lys Ser Thr Leu Lys Ile Gly Gln Arg
1160 1165 1170
Gly Asn Glu Lys Ile Asp Ile Ile Gly Asn His Val Met Glu Gly
1175 1180 1185
Ser Ser Tyr Arg Asp Met Thr Phe Lys Ser Asn Ile Glu Ala Lys
1190 1195 1200
Ile Gly Asn Ala Arg Tyr Lys Lys Asn Phe Val Leu Tyr Asn Gln
1205 1210 1215
Glu Ser Lys Met Gly Val Glu Trp Gln Val Ala Ser Gln Glu Gly
1220 1225 1230
Gly Lys Val Ile Glu Leu Glu Met Met Leu Ile Arg Ser Gly Glu
1235 1240 1245
Thr Ser Gln Val Lys Phe Leu Leu Asp Ile Pro Glu Arg Met Lys
1250 1255 1260
Lys Val Leu Leu Glu Ala Ser Ala Ala Gly Gln Gly Ser Ser Gln
1265 1270 1275
Tyr Gln Val Arg Ala Met Ala Lys Tyr Gly Glu Ser Pro Ile Phe
1280 1285 1290
His Val Glu Gly Pro Val Thr Ala Met Leu Ser Ser Lys Asn Thr
1295 1300 1305
His Leu Lys Thr Glu Leu Arg Thr Val Leu Leu Arg Ser Gln Pro
1310 1315 1320
Tyr Thr Val Thr Thr Ser Leu Val Met Met His Gly Lys Gln Ala
1325 1330 1335
Val Val Phe Glu Leu Lys Asp Arg Glu Glu His Leu Ile Thr Val
1340 1345 1350
Gln Trp Asn Met Ala Thr Arg Asp Gly Gln Glu Thr His Leu Asp
1355 1360 1365
Phe Lys Met Leu Ile Pro Ser Met Ile Glu Lys Thr Met Asn Ala
1370 1375 1380
Ile Val Ser Glu Lys Val Phe His Leu Ser Val Asn Gln Leu Ile
1385 1390 1395
Gly Pro Lys Ser Ser Ser Pro Leu Arg Arg Lys Gly Phe Leu Asp
1400 1405 1410
Val Asp Phe Glu Gly Lys Arg Ala Asn Val Glu Phe Ala Trp Asp
1415 1420 1425
Ala Asp Arg Asn Pro Asn Lys Lys Ile Lys Ala Glu Val Lys Met
1430 1435 1440
Val Asn Pro Leu Ser Thr Leu Arg Asp Cys Val Val Gln Gly Asn
1445 1450 1455
Trp Ala Tyr Leu Glu Arg Gln His Gln Phe Lys Ala Glu Leu Lys
1460 1465 1470
Leu Ser Asp Ile Arg Ser Trp Phe Val Gly Arg Asn Ser Leu Met
1475 1480 1485
Leu Glu Val Thr Asn Pro Asn Gln Gln Met Tyr Lys Met Asn Ser
1490 1495 1500
Ile Leu Met Val Glu Lys Lys Gly Ser Gly Pro Lys Val Gly Ala
1505 1510 1515
Asp Ile Thr Phe Arg Thr Pro Glu Asn Arg Glu Tyr Lys Trp Asn
1520 1525 1530
Ser Glu Ser Ser Leu Glu Cys Arg Glu Gly Leu Gln Asn Val Arg
1535 1540 1545
Leu Met Thr Lys Ala Asp Leu Val Trp Pro Glu Gly Arg Gln Ser
1550 1555 1560
Ile Val Asn Leu Glu Ala Met His Arg Trp Thr Pro Ser Gln Arg
1565 1570 1575
Glu Ala Glu Leu Lys Ile Glu Val Thr Cys Pro Ser Leu Pro Gln
1580 1585 1590
Pro Ile Lys Thr Lys Leu Gln Leu Asn Asn Gln Gln Gly Glu Tyr
1595 1600 1605
Ser Thr Lys Trp Val Ile Glu Met Gly Phe Pro Val Asn Gly Ala
1610 1615 1620
Met Tyr Lys Leu Lys Leu Ser Pro Glu His Gly Val Gln Gly Phe
1625 1630 1635
Glu Val Glu Leu Asn Leu Glu Glu Val Leu Lys Leu Leu Lys Ala
1640 1645 1650
Ile Asp His Leu Ile Ser Ser Ser Ser Leu Ser Met Ser Asp Ser
1655 1660 1665
Pro Arg Arg Leu Leu Phe Ile Val Leu Thr Thr Asn Ile Met Thr
1670 1675 1680
Thr Ile Leu Ile Pro Cys Cys Leu Met Ser Pro Ser Arg Thr Met
1685 1690 1695
Glu Gly Gly Cys Gly Cys Asn Thr Cys Thr Gly Pro Ser Cys Ala
1700 1705 1710
Asp Cys His Cys Ser Phe Val Pro His Lys Gly Leu Ser Asp Ser
1715 1720 1725
Lys Tyr Glu Ile Ala Phe Arg Arg Ser His Ser Asp Trp Ser Gly
1730 1735 1740
Glu Ser Arg Tyr Glu Gly Arg Val Ser His Pro Gly Leu Glu Arg
1745 1750 1755
Asp Arg Arg Ile Asp Ile Gln Leu Arg Arg Glu Glu Gln Lys Val
1760 1765 1770
Thr Gly Ser Val Glu Leu Asp Ile Phe Leu Arg Pro Glu Asp Lys
1775 1780 1785
Ile Thr Gly Lys Leu Glu Ser Leu Ile Tyr Ala Arg Asn Thr Val
1790 1795 1800
Ile Val Glu Ala Lys Leu Glu Gly Lys Val Leu Lys Asp His Pro
1805 1810 1815
Lys Val Ile Val Arg Gly Ala Tyr Gly Pro Ser Asn Val Gly Phe
1820 1825 1830
Asp Ile Lys Leu His Lys Thr His Ser Ser Pro Thr Ser Phe Arg
1835 1840 1845
Met Ser Gly Arg Tyr Glu Lys Arg Thr Ala Arg Asn Ala Ala Ala
1850 1855 1860
Ser Phe Ile Ile Glu Asn Glu His Gln Lys Thr Ile Asp Ile Ser
1865 1870 1875
Ile Ala Leu His Pro His Gln Ser Pro Trp Cys Tyr Gly Val Arg
1880 1885 1890
Ala Glu Ala Lys Ala Lys Ser Ser Ile Ile Gly Thr Tyr Asp Ile
1895 1900 1905
Tyr Ser Glu Leu Cys Lys Pro Gly Phe Val Ser Leu Thr Thr Lys
1910 1915 1920
Lys His Gly Ser Asp Lys Met Tyr Ile Thr Lys Leu Gly Ile Glu
1925 1930 1935
Gly Met Lys Asn Ile Glu Ala Ser Ile Leu Glu Ala Asn Pro Gln
1940 1945 1950
Thr Met Glu Lys Arg Pro Leu Gly Met Ala Arg Met Val Leu Thr
1955 1960 1965
Ser Pro Thr Met Met Lys Leu Glu Thr Lys Tyr Glu Gly Asp Lys
1970 1975 1980
Leu His Glu Ile Lys Ser Thr Val Arg Asp Met Trp Trp Arg Leu
1985 1990 1995
Val Ser Ser Ala Gly Asn Gly Met Asp Ser Leu Cys Ser Glu Val
2000 2005 2010
Leu Gln Glu Gly Ser Gly Ser Pro Ser Gly His Met Ser Ser Val
2015 2020 2025
Trp Arg Glu Ile Lys Asn Glu Ala Ser Arg Ile Tyr Ser Asp Leu
2030 2035 2040
Glu Asn Asp Leu Val Ile Pro Lys Tyr Glu Lys Leu Arg Glu Trp
2045 2050 2055
Leu His Gly Gly Ile Leu Ser Asn Ile Ala Glu Gly Cys Ser Lys
2060 2065 2070
Val Trp Ser His Tyr Ala His Phe Gln Ser Ser Leu Ser Ser Ser
2075 2080 2085
Val Ser Asn Met Ile Arg Thr Ile Arg Glu Glu Phe Pro Gly Leu
2090 2095 2100
Thr Arg Val Val Thr Glu Val Val Met Gly Thr Ala Arg Gly Leu
2105 2110 2115
Gln Thr Gly Glu Met Pro Glu Val Phe Arg Arg Trp Trp Asn Asp
2120 2125 2130
Phe Leu Glu Ser Ser Phe Cys Arg Ala Ile Ala Ser Asp Phe Glu
2135 2140 2145
Ser Leu Trp Ser Glu His Gln Glu Glu Tyr Gln Gly Leu Gln Gln
2150 2155 2160
Ile Trp Arg Lys Ile Lys Asn Thr Leu Ala Lys Asp Val Asn Arg
2165 2170 2175
Gln Arg Arg Asn Leu Met His Tyr Lys Lys Pro Arg His Leu Val
2180 2185 2190
Asn Trp Ile Val His Asp Met Asn Phe Glu Arg Met Val Phe Lys
2195 2200 2205
Gly Val Asp Lys Val Ile Lys Asn Val Val Gln Lys Ala Leu Phe
2210 2215 2220
Val Pro Phe Gln Ile Asp Gly Asn His Phe Gln Leu Gln Leu Pro
2225 2230 2235
Ile Arg Arg Pro Val His Ser Leu Pro Gln Ala Leu Ser Tyr Val
2240 2245 2250
Ser Met Asn Pro Thr Pro Val Val Asp Arg Ala Leu Trp Trp Phe
2255 2260 2265
Glu Ala Leu Met Pro Thr Pro Val Asp Asn Ile Val Trp Ala Tyr
2270 2275 2280
Tyr Lys Phe Leu Pro Arg His Ala Arg Tyr Leu Leu Pro Pro Tyr
2285 2290 2295
Asn His Thr Ala Met Val Val Asp Gly Ser Glu Ile Leu Thr Phe
2300 2305 2310
Asp Gly Val Val Leu Arg Val Pro His Ser Pro Cys Lys Val Leu
2315 2320 2325
Leu Ala Gln Tyr Lys Thr His Ser Leu Ile Met Gln Asn Gln Gln
2330 2335 2340
Pro Gly His Leu Pro His Phe Ile Leu Lys Ala Ala Gly Ala Thr
2345 2350 2355
Val Glu Val Lys Pro Asp Phe Val Val Thr Val Asn Gly Asn Pro
2360 2365 2370
Val Ser Gly Pro Arg Glu Val Gln Gly Glu Val Val Ile Met Lys
2375 2380 2385
Glu Asn Glu Lys Ile Lys Val Arg Thr Pro Phe Ile Thr Leu Arg
2390 2395 2400
Val Tyr Lys Asp Ser Arg Thr Ala Ser Val Glu Val Ser Gly Trp
2405 2410 2415
Thr Phe Gly Arg Ile Ala Gly Leu Leu Gly Ile Tyr Asp Gly Glu
2420 2425 2430
Lys Ala Thr Asp Arg Leu Thr Pro Gln Gly Thr Arg Ala Ser Asn
2435 2440 2445
Leu Gln Glu Leu Val Lys Ser Trp Gln Glu Asn Pro Gln Cys Glu
2450 2455 2460
Thr Pro His Val Ala Pro Met Ser Pro Met Gln Val Pro Val Val
2465 2470 2475
His Met Leu His Cys Gln Thr Leu Phe Gly Val Arg Ser Arg Cys
2480 2485 2490
Asn Pro Val Val His Pro Gly Pro Phe Arg Lys Met Cys Phe Ala
2495 2500 2505
Ser Lys Asn Ala Cys His Val Ala Lys Ala Tyr Arg Ala Met Cys
2510 2515 2520
Glu Thr Lys Gly Ile Lys Glu Thr Phe Pro Leu Gly Cys
2525 2530 2535
<210> 3
<211> 39
<212> DNA
<213> 人工序列
<400> 3
taatacgact cactataggt gccaagaaaa agctcctgt 39
<210> 4
<211> 39
<212> DNA
<213> 人工序列
<400> 4
taatacgact cactataggg ccaaaggttg gtgcatagt 39
<210> 5
<211> 22
<212> DNA
<213> 人工序列
<400> 5
tctggcgaca gcctcagctg gt 22
<210> 6
<211> 22
<212> DNA
<213> 人工序列
<400> 6
ctggagcagt caaggttatg gt 22
<210> 7
<211> 22
<212> DNA
<213> 人工序列
<400> 7
gccagagaaa atggagttgg tg 22
<210> 8
<211> 22
<212> DNA
<213> 人工序列
<400> 8
gtcaggcgaa acatcacaag tc 22
<210> 9
<211> 23
<212> DNA
<213> 人工序列
<400> 9
ctgttgcttg atgtcaccct ctc 23
<210> 10
<211> 23
<212> DNA
<213> 人工序列
<400> 10
ttgatgacag tgaacgttcc tga 23
<210> 11
<211> 22
<212> DNA
<213> 人工序列
<400> 11
tacagagcac acgattccag ac 22
<210> 12
<211> 22
<212> DNA
<213> 人工序列
<400> 12
ttggtactga gagcttcctt gg 22
<210> 13
<211> 22
<212> DNA
<213> 人工序列
<400> 13
cctgtgacct tctgttcctc tc 22
<210> 14
<211> 22
<212> DNA
<213> 人工序列
<400> 14
accgtgcatt atggtggctt ga 22
<210> 15
<211> 23
<212> DNA
<213> 人工序列
<400> 15
tcttgttaac tggatcgtcc acg 23
<210> 16
<211> 23
<212> DNA
<213> 人工序列
<400> 16
aagctctctt cgtacctgtt cag 23
<210> 17
<211> 24
<212> DNA
<213> 人工序列
<400> 17
attacaggtg tgcagagttc cctc 24
<210> 18
<211> 22
<212> DNA
<213> 人工序列
<400> 18
aagtacccta cctgaaccac ct 22

Claims (1)

1.青虾卵黄蛋白原Vg基因在延缓雌性青虾卵巢发育中的应用;所述的青虾卵黄蛋白原Vg基因的核苷酸序列如SEQ ID NO.1中的第35位~第7645位所示;包括如下步骤:对青虾DNA样本中的青虾卵黄蛋白原Vg基因进行PCR扩增,将扩增产物进行体外转录合成dsRNA,再将dsRNA以注射到青虾的围心腔内;PCR扩增中使用的上下游引物的序列如SEQ ID NO.3~4所示;所述的注射步骤中的注射剂量是4μg/g。
CN201410456699.2A 2014-09-09 2014-09-09 青虾卵黄蛋白原Vg基因、编码蛋白及应用 Expired - Fee Related CN104193814B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410456699.2A CN104193814B (zh) 2014-09-09 2014-09-09 青虾卵黄蛋白原Vg基因、编码蛋白及应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410456699.2A CN104193814B (zh) 2014-09-09 2014-09-09 青虾卵黄蛋白原Vg基因、编码蛋白及应用

Publications (2)

Publication Number Publication Date
CN104193814A CN104193814A (zh) 2014-12-10
CN104193814B true CN104193814B (zh) 2017-09-05

Family

ID=52079210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410456699.2A Expired - Fee Related CN104193814B (zh) 2014-09-09 2014-09-09 青虾卵黄蛋白原Vg基因、编码蛋白及应用

Country Status (1)

Country Link
CN (1) CN104193814B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108048468B (zh) * 2017-12-27 2020-12-29 中国水产科学研究院淡水渔业研究中心 青虾视蛋白基因及其编码的蛋白和应用
CN109251931B (zh) * 2018-09-18 2022-04-01 中国水产科学研究院淡水渔业研究中心 青虾Rev3基因及其编码蛋白和应用
EP4013771A4 (en) * 2019-08-15 2023-09-06 National Institute for Biotechnology in the Negev Ltd. RELEASE PEPTIDES AND METHODS OF USE THEREOF
CN112979778B (zh) * 2019-12-13 2022-04-22 天津师范大学 介导外源蛋白内吞的多肽和核酸及其应用和在异足新米虾中进行基因编辑的方法
CN111088257B (zh) * 2019-12-31 2022-08-02 河北大学 一种脊尾白虾卵黄蛋白结合蛋白基因及其应用
CN112575000B (zh) * 2020-12-25 2023-07-11 中国水产科学研究院淡水渔业研究中心 青虾sdhb基因及其编码的蛋白和应用
CN112852846B (zh) * 2021-02-05 2021-11-23 中国水产科学研究院淡水渔业研究中心 青虾Cathepsin L基因、其dsRNA及应用
CN114395572B (zh) * 2022-01-12 2023-03-24 中国水产科学研究院淡水渔业研究中心 青虾legumain-like基因及其dsRNA的应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Vitellogenin RNAi halts ovarian growth and diverts reproductive proteins and lipids in young grasshopppers;Derek R Tokar et al.;《Integrative and Comparative Biology》;20140611;第54卷(第5期);931-941 *
日本沼虾卵黄蛋白原代谢相关基因的克隆和表达研究;赵卫红;《中国博士学位论文全文数据库(农业科技辑)》;20110715;D052-8 *

Also Published As

Publication number Publication date
CN104193814A (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
CN104193814B (zh) 青虾卵黄蛋白原Vg基因、编码蛋白及应用
Ma et al. Molecular cloning, expression analysis of insulin-like growth factor I (IGF-I) gene and IGF-I serum concentration in female and male Tongue sole (Cynoglossus semilaevis)
EA200600050A1 (ru) Способы получения инсулина в растениях
CN110066798A (zh) 褐飞虱NlInR基因作为靶点在制备防治褐飞虱药物中的应用
Kasagi et al. Molecular and functional characterization of opsins in barfin flounder (Verasper moseri)
CN104592378B (zh) 一种青虾FoxL2蛋白及其编码基因与应用
Pan et al. A new species of the genus Rhacophorus (Anura: Rhacophoridae) from Dabie Mountains in East China
CN106172129A (zh) 一种鱼类生长和多个抗逆性能综合选育及验证方法
Tang et al. Molecular cloning, characterization and expression analysis of multiple leptin genes in Jian carp (Cyprinus carpio var. Jian)
Haraguchi et al. Nucleotide sequence and expression of relaxin-like gonad-stimulating peptide gene in starfish Asterina pectinifera
CN108048468A (zh) 青虾视蛋白基因及其编码的蛋白和应用
Wang et al. Two HSP90 genes in mandarin fish Siniperca chuatsi: identification, characterization and their specific expression profiles during embryogenesis and under stresses
CN106916824A (zh) 桔小实蝇Taiman基因和其可变剪切体检测方法及其dsRNA
CN103421807A (zh) OsMYB91转录因子基因在水稻发育和抗逆中的应用
CN103642797B (zh) 一种团头鲂肌间骨总rna提取方法
CN109456976B (zh) 舞毒蛾JHAMT基因、其编码蛋白及其dsRNA在害虫防治中的应用
CN108218974A (zh) 一种曼氏无针乌贼神经肽及其用途
CN104313031B (zh) 青虾蜕皮抑制激素基因及其在加速青虾蜕皮和生长中的应用
CN105969745B (zh) 鱼类低氧耐受基因及其用途
CN103626864A (zh) 一种促进大黄鱼生长的可溶性重组蛋白及其制备
CN112941020A (zh) 一种鸡环状rna在促进成肌细胞的增殖的应用
CN110592095A (zh) 曼氏无针乌贼维甲酸x受体基因的克隆和表达
CN108728445A (zh) 一种carp-1基因及其应用
CN104212813A (zh) 青虾性腺抑制激素基因、加速卵巢发育的试剂盒及方法
Cheng et al. Molecular cloning and expression analysis of CD79a and CD79b in rainbow trout (Oncorhynchus mykiss) after bacterial, parasitic, and viral infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170905

Termination date: 20180909